|本期目录/Table of Contents|

[1]李元霄,林汉斌,刘昌云,等.CYP2C19基因多态性对接受椎动脉支架患者预后的影响[J].福建医科大学学报,2020,54(01):18-22.
 LI Yuanxiao,LIN Hanbin,LIU Changyun,et al.Effect of CYP2C19 Gene Polymorphism on Prognosis of Patients Receiving Vertebral Artery[J].Journal of Fujian Medical University,2020,54(01):18-22.
点击复制

CYP2C19基因多态性对接受椎动脉支架患者预后的影响(PDF)
分享到:

《福建医科大学学报》[ISSN:1672-4194/CN:35-1192/R]

卷:
第54卷
期数:
2020年01期
页码:
18-22
栏目:
临床研究
出版日期:
2020-02-28

文章信息/Info

Title:
Effect of CYP2C19 Gene Polymorphism on Prognosis of Patients Receiving Vertebral Artery
文章编号:
1672-4194(2020)01-0018-05
作者:
李元霄 林汉斌 刘昌云 陈枝挺
福建医科大学 附属协和医院神经内科,福州 350001
Author(s):
LI Yuanxiao1 LIN Hanbin1 LIU Changyun1 CHEN Zhiting2
Department of Neurology, Fujian Medical University Union Hospital, Fuzhou 350001, China
关键词:
椎底动脉供血不足 多态现象 遗传 多态性 限制性片段长度 血管疾病 支架 脑梗死
Keywords:
vertebrobasilar insufficiency polymorphism genetic polymorphism restriction fragment length vascular diseases stents brain infarction
分类号:
R392.2; R654.3; R743.9
DOI:
-
文献标志码:
A
摘要:
目的 探讨在椎动脉支架置入术后患者的CYP2C19基因型分布与椎动脉支架内再发狭窄、复发性卒中和出血等预后不良事件的关系。 方法 回顾性分析205例接受CYP2C19基因检测的椎动脉狭窄并行支架置入术患者的临床资料。根据CYP2C19基因型所致肝脏对药物代谢情况,将椎动脉支架置入术后患者分为快、中、慢代谢3组,观察预后。 结果 3组患者在接受氯吡格雷及阿司匹林双联抗血小板治疗前,血小板抑制率未达标(ADP%<50%)的患者数量比较,差别无统计学意义(P>0.05); 接受氯吡格雷及阿司匹林双联抗血小板治疗6月后,差别有统计学意义(P<0.05)。3组患者在椎动脉支架置入术后规律氯吡格雷及阿司匹林双联抗血小板治疗6月内椎动脉支架内再狭窄和复发性脑梗死患者数量比较,差别有统计学意义(P<0.05),但对于其常见副作用如颅内出血及胃肠道、牙龈等其他部位出血的患者数量比较,差别无统计学意义(P>0.05)。 结论 在椎动脉支架置入术后患者中,CYP2C19基因快代谢型使用氯吡格雷及阿司匹林双联抗血小板治疗预防椎动脉支架内再狭窄、复发性脑梗死的获益明显优于中代谢型和慢代谢型,且颅内出血及胃肠道、牙龈等其他部位出血影响不明显。在椎动脉支架置入术后常规使用氯吡格雷及阿司匹林双联抗血小板治疗的患者中,CYP2C19基因多态性为影响患者椎动脉支架内再狭窄和复发性脑梗死的重要危险因素。
Abstract:
Objective To investigate the relationship between the distribution of CYP2C19 genotype and adverse prognostic events such as restenosis, recurrent stroke and hemorrhage in patients with vertebral artery stenting. Methods The clinical data of 205 patients with vertebral artery stenosis and stent implantation were analyzed retrospectively. According to the liver metabolism caused by CYP2C19 genotype, patients after vertebral artery stent implantation were divided into three groups: fast metabolism in group A, moderate metabolism in group B, and slow metabolism in group C. The prognosis was observed. Results There was no significant difference in platelet inhibition rate(adenosine diphosphate inhibition rate,ADP%<50%)between the three groups before antiplatelet treatment with clopidogrel and aspirin(P>0.05). There was significant difference in platelet inhibition rate between the three groups after 6 months of antiplatelet treatment with clopidogrel and aspirin(P<0.05). During the 6 months of oral clopidogrel and aspirin dual antiplatelet therapy after vertebral artery stent implantation, there was a significant difference in the number of patients with recurrent cerebral infarction and restenosis of vertebral artery stent in the three groups(P<0.05). However, there was no statistical difference in the number of patients with common side effects such as intracranial hemorrhage and bleeding in other parts of the gastrointestinal tract and gingiva among the three groups(P>0.05). Conclusions In patients with vertebral artery stent implantation, clopidogrel and aspirin dual antiplatelet therapy, CYP2C19 gene fast metabolic type to prevent restenosis of vertebral artery stent, recurrent cerebral infarction benefits significantly better than the moderate metabolic type and slow metabolic type, but the effect of intracranial hemorrhage and bleeding in other parts of gastrointestinal tract and gingiva was not obvious in the patients. In the use of the dual anti-platelet therapy of chlordecay and aspirin after vertebral artery stenting, CYP2C19 gene polymorphism is an important risk factor in patients with vertebral artery restenosis and recurrent cerebral infarction.

参考文献/References:

[1] 中国卒中学会重症脑血管病分会专家撰写组.急性缺血性脑卒中血管内治疗术后监护与管理中国专家共识[J].中华医学杂志,2017,97(3):162-172.
[2] 崔丽英,郑 晴,倪 俊,等. 重视推广规范的卒中二级预防措施[J]. 中华神经科杂志,2016,49(12):905.
[3] 症状性颅内动脉粥样硬化性狭窄血管内治疗专家共识组. 症状性颅内动脉粥样硬化性狭窄血管内治疗中国专家共识[J]. 中华内科杂志,2013,52(3):271-275.
[4] Orford J L,Panayotis F,Steven M,et al. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation[J]. American Heart J,2004,147(3):463-467.
[5] 中华医学会神经病学分会脑血管病学组缺血性脑血管病血管内介入诊疗指南撰写组. 中国缺血性脑血管病血管内介入诊疗指南[J]. 中华神经科杂志,2011,44(12):863-869.
[6] Jiang Y,Xu X,Wen Z,et al. In-stent restenosis after vertebral artery stenting[J]. International J Cardiology,2015,187(1):430-433.
[7] 周 峰,马 黎,傅国萍,等. 椎动脉支架置入术的临床长期随访[J]. 中华老年心脑血管病杂志,2018,20(5):74-78.
[8] Scott S A,Sangkuhl K,Gardner E,et al. Clinical pharmacogenetics implementation consortium guidelines for cytochrome P450-2C19(CYP2C19)genotype and clopidogrel therapy[J]. Clinical Pharmacology & Therapeutics,2011,90(2):328.
[9] 中华医学会神经病学分会. 中国缺血性脑血管病血管内介入诊疗指南2015[J]. 中华神经科杂志,2015,48(10):830-837.
[10] Melis R,Lyon E,Mcmillin G A,et al. Determination of CYP2D6, CYP2C9 and CYP2C19 genotypes with Tag-ItTM mutation detection assays[J]. Expert Review of Molecular Diagnostics,2006,6(6):811.
[11] Vargas-Alarcón,Gilberto,Ramírez-Bello, et al. Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican mestizos population[J]. Molecular Biology Reports,2014,41(10):7023-7029.
[12] Yi X Y,Zhang B,Wang C,et al. Genetic polymorphisms of ALOX5AP and CYP3A5 increase susceptibility to ischemic stroke and are associated with atherothrombotic events in stroke patients[J]. Stroke & Cerebrovascular Diseases the Official J National Stroke Association,2015,24(3):521-529.
[13] Shuldiner A R. CYP2C19 and clopidogrel response: more than validation in the real world[J]. Clinical Pharmacology & Therapeutics,2012,91(2):170.
[14] Hwang S J,Jeong Y H,Kim I S,et al. The cytochrome 2C19*2 and *3 alleles attenuate response to clopidogrel similarly in east asian patients undergoing elective percutaneous coronary intervention[J]. Thrombosis Research,2011,127(1):23-28.
[15] Jeong H E,Lee S J,Cha E Y,et al. Development of a multiplex and cost-effective genotype test toward more personalized medicine for the antiplatelet drug clopidogrel[J]. International J Molecular Sciences,2014,15(5):7699-7710.
[16] Oestreich J H,Best L G,Dobesh P P, et al. Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in native americans[J]. American Heart J,2014,167(3):413-438.
[17] Kupstyte N,Zaliunas R,Tatarunas V,et al. Effect of clinical factors and gene polymorphism of CYP2C19*2, *17 and CYP4F2*3 on early stent thrombosis[J]. Pharmacogenomics,2015,16(3):181-189.
[18] Xie X,Ma Y T,Yang Y N,et al. CYP2C19 Phenotype, stent thrombosis, myocardial infarction, and mortality in patients with coronary stent placement in a chinese population[J]. PLoS One,2013,8(3):e59344.
[19] Barnes P J. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease[J]. J Allergy & Clinical Immunology,2013,131(3):636-645.
[20] Li S,Shi Y,Wang H,et al. Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus assessed by follow-up optical coherence tomography in chinese patients receiving clopidogrel[J]. J Thrombosis & Thrombolysis,2015,40(1):88.
[21] Khosravi A,Bideh F Z,Roghani F,et al. Carotid arterial stent implantation follow-up and results in 50 patients: preliminary report[J]. Electronic Physician,2018,10(2):6400-6405.
[22] Cvjetko I,Bjelovar D I,Cvjetko T,et al. Acute carotid artery stent thrombosis[J]. Cardiovasc Intervent Radiol,2018,41(2):355-356.
[23] Zheng D,Mingyue Z,Wei S,et al. The incidence and risk factors of in-stent restenosis for vertebrobasilar artery stenting[J]. World Neurosurgery,2017,110(2):937-941.
[24] Haijun L,Qixiao L,Yuanyuan J,et al. Disruption of Th17 treg balance in the sputum of patients with chronic obstructive pulmonary disease[J]. American J Medical Sciences,2015,349(5):392-397.
[25] Staymann A N,Nogueira R G, Gupta R,et al. A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis[J]. J Vascular Surgery,2012,55(1):2212-2216. [26] Cai X L, Wei Y X,Ren S J,et al. Balloon-expandable stent angioplasty in the treatment of vertebral artery stenosis in the V2 segment[J]. Videosurgery and Other Miniinvasive Techniques,2018,13(2):227-232. [27] Chen W H, Huang F,Lin M,et al. Incidence and predictors of the in-stent restenosis after vertebral artery ostium stenting[J]. J Stroke and Cerebrovascular Diseases,2018,27(11):3030-3035. [28] Zhou Z,Yin Q,Xu G,et al. Influence of vessel size and tortuosity on in-stent restenosis after stent implantation in the vertebral artery ostium[J]. Cardiovascular & Interventional Radiology,2011,34(3):481-487. [29] Hung C S,Lin M S,Chen Y H,et al. Prognostic factors for neurologic outcome in patients with carotid artery stenting[J]. Acta Cardiologica Sinica,2016,32(2):10.

相似文献/References:

[1]黄荣东,黄之敏,周小巧,等.NQO1 C609T基因多态性与肺癌易感性关系的Meta分析[J].福建医科大学学报,2014,48(03):141.
 HUANG Rongdong,HUANG Zhimin,ZHOU Xiaoqiao,et al.Association of NQO1 C609T Gene Polymorphism and the Risk of Lung Cancer: a Meta-analysis[J].Journal of Fujian Medical University,2014,48(01):141.
[2]蔡江萍,李国前,慕容慎行,等.LRRK2基因多态性与散发性阿尔茨海默病相关性的研究[J].福建医科大学学报,2014,48(03):169.
 CAI Jiangping,LI Guoqian,MURONG Shenxing,et al.Association between Polymorphisms of the LRRK2 Gene and Sporadic Alzheimer’s Disease[J].Journal of Fujian Medical University,2014,48(01):169.
[3]林善明,李增棋,王航,等.华法林个体化剂量与CYP2C9/VKORC1基因组之间的关系[J].福建医科大学学报,2015,49(02):120.
 LIN Shanming,LI Zengqi,WAN Hang,et al.Investigation of the Relationship between the Individual Warfarin Dosing and the Pharmacogenomics[J].Journal of Fujian Medical University,2015,49(01):120.
[4]郑智华,黄爱民,高美钦,等.APEX1单核苷酸多态性与肝癌易感性关系的研究[J].福建医科大学学报,2016,50(02):88.
 ZHENG Zhihua,HUANG Aimin,GAO Meiqin,et al.Association of Single Nucleotide Polymorphism of APEX1 Gene with Susceptibility to Hepatocellular Carcinoma[J].Journal of Fujian Medical University,2016,50(01):88.
[5]王雪金,罗湘闽.TNF-a-1 031,-238,-308基因多态性与卵巢早衰的关系[J].福建医科大学学报,2016,50(03):167.
 WANG Xuejin,LUO Xiangmin.Association of TNF-a-1 031,-238,-308 Gene Polymorphismswith Premature Ovarian Failure in Chinese Women[J].Journal of Fujian Medical University,2016,50(01):167.
[6]黄华佗,陆玉兰,王 荣,等.中国广西人群miRNA1792基因簇启动子区rs1491034和rs982873遗传多态性研究[J].福建医科大学学报,2017,51(04):212.
 HUANG Huatuo,LU Yulan,WANG Rong,et al.Exploration of Genetic Polymorphism of rs1491034 and rs982873in the Promoter of miRNA-17-92 Cluster in China Guangxi Population[J].Journal of Fujian Medical University,2017,51(01):212.
[7]郑伟丽,林万尊,陈婷,等.循环肿瘤细胞与外周血检测非小细胞肺癌XRCC1多态性的相关研究[J].福建医科大学学报,2018,52(04):225.
 ZHENG Weili,LIN Wanzun,CHEN Ting,et al.The Study Applying Circulating Tumor Cells and Peripheral Blood to Detect XRCC1 Gene Polymorphism[J].Journal of Fujian Medical University,2018,52(01):225.
[8]赵红,顾定伟,李广平,等.唐山汉族CYP11B2-344 T/C多态在冠状动脉粥样硬化性心脏病及其高危人群中的分布研究[J].福建医科大学学报,2018,52(04):239.
 ZHAO Hong,GU Dingwei,LI Guangping,et al.Distribution of CYP11B2-344 T/C Polymorphism in Han Population of Tangshan at High Risk of Coronary Heart Disease[J].Journal of Fujian Medical University,2018,52(01):239.
[9]赵会贤,黄宛祯,黄丽英.不同产地和不同环境生长的金线莲的ISSR遗传特性分析[J].福建医科大学学报,2018,52(05):281.
 ZHAO Huixian,HUANG Wanzhen,HUANG Liying.ISSR Analysis on Genetic Characteristics of Anoectochilus Roxburghii fromDifferent Habitats and Growth Patterns[J].Journal of Fujian Medical University,2018,52(01):281.
[10]马敏明,李盈科,袁红斌.ADRB1基因多态性与结直肠癌患者疼痛敏感度及腹腔镜术后芬太尼镇痛效果的关联[J].福建医科大学学报,2020,54(02):78.
 MA Minming,LI Yingke,YUAN Hongbin.The Correlation of ADRB1 Gene Polymorphism with Pain Sensitivity and AnalgesicEffect of Fentanyl after Laparoscopic Resection in Colorectal Cancer Patients[J].Journal of Fujian Medical University,2020,54(01):78.

备注/Memo

备注/Memo:
收稿日期: 2019-01-30 作者简介: 李元霄,男,医学硕士,主治医师 通讯作者: 刘昌云. Email:13365910778@189.cn
更新日期/Last Update: 2020-01-30